SCHEDULE 13D/A

DAMORA THERAPEUTICS INC

Common Stock, par value $0.00001 per share · CUSIP: 36322Q206

Event date: 2026-02-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Fairmount Funds Management LLCReported CIK 0001802528

  Shares: 8,713,000.00 · Class: 19.99%

• Fairmount Healthcare Fund II L.P.Reported CIK 0001769651

  Shares: 5,809,000.00 · Class: 13.32%

• Fairmount Healthcare Co-Invest V L.P.Reported CIK 0002091559

  Shares: 2,904,000.00 · Class: 6.66%

• Peter Evan HarwinReported CIK 0001663607

  Shares: 8,713,000.00 · Class: 19.99%

• Tomas KiselakReported CIK 0001830177

  Shares: 8,713,000.00 · Class: 19.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.